Accueil
Synopsis programme
Test CME
Mycology from bench to bedside
09 July 2021
6. Fungal infection & disease
,
1-hour ePoster Review
•
S222
•
09:30
>
10:30
•
Mycology from bench to bedside
•
6. Fungal infections
•
1017
•
Breakthrough invasive fungal infections in high-risk oncohaematological patients with different primary antifungal prophylaxis strategies
>
A.
Andres Nicolas
REARTE
(Buenos Aires)
•
1070
•
Performance validation of a novel <em>Aspergillus</em> Galactomannan kit
>
H.
He
WANG
(Beijing)
•
1080
•
An open-label study in healthy volunteers to evaluate the effect of fluconazole upon the pharmacokinetics of olorofim
>
K.
Karen
CORNELISSEN
(Manchester)
•
1676
•
Risk factors and predictors of mortality of candidaemia among patients hospitalised in a Swiss university hospital
>
M.
Matthaios
PAPADIMITRIOU-OLIVGERIS
(Lausanne)
•
195
•
Invasive aspergillosis in adult patients with rheumatic diseases
>
N.
Nikolai
KLIMKO
(Saint Petersburg)
•
1960
•
Multi-centre registry of patients receiving systemic mould-active triazoles for treatment or prophylaxis of invasive fungal infections
>
L.
Luis
OSTROSKY-ZEICHNER
(Houston)
•
1978
•
Antifungal consumption before and during the first wave of COVID-19: a French nationwide survey
>
F.
Florence
LIEUTIER-COLAS
(Strasbourg)
•
244
•
<em>In vitro </em>assay of zinc oxide nanoparticles efficiency in comparison with conventional antifungals against planktonic and biofilm-forming <em>Candida albicans</em> isolates from patients with cardiovascular disease
>
O.
Omar Sadik
SHALAL
(Baghdad)
•
2469
•
(1?3)-ß-D-glucan and mannan guided early termination of antifungal therapy in ICU patients: a prospective randomized intervention study (REDUCE-AM)
>
J.
Jürgen
HELD
(Erlangen)
•
4048
•
The emergence of multidrug-resistant <em>Candida duobushaemolnii</em>: using whole genome sequencing to describe the population structure
>
X.
Xin Fei
CHEN
(Beijing)
•
4211
•
Towards a program to optimise the use of antifungals in a universitary third level hospital
>
P.
Paloma
MERINO-AMADOR
(Madrid)
•
4390
•
Agreement of broncoalveolar lavage (BAL)-<em>Aspergillus</em>-PCR and BAL-galactomannan (GM): can BAL-GM overestimate the risk of probable COVID-19-associated pulmonary aspergillosis in ICU patients?
>
S.
Silvia
DETTORI
(Genoa)
•
445
•
<em>Aspergillus </em>sensitization in severe asthma patients
>
N.
Nikolai
KLIMKO
(Saint Petersburg)
•
594
•
Treatment with isavuconazole (ISA) for invasive fungal infections (IFI) in solid organ transplant recipients (SOTR): real-life experience
>
A.
Arnau
MONFORTE PALLARES
(Barcelona)
Copyright © key4events - All rights reserved